Related Experiment Video
Updated: Aug 6, 2025

06:50
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
2.6K
ELISA array-based immunoassay for multiplex detection of osteoporosis-relevant biomarkers
Yongjin Li1, Jianfeng Ni2, Jiali Gu1
1College of Life Sciences, Huzhou University, Huzhou, 313000, China.
Bioanalysis
|March 15, 2023
Summary
A new ELISA array immunoassay enables simultaneous detection of multiple osteoporosis biomarkers. This method offers a feasible and productive approach for multiplex biomarker measurement in osteoporosis research.
Area of Science:
- Biochemistry
- Immunology
- Biomarker Discovery
Background:
- Osteoporosis diagnosis relies on single biomarker detection.
- Multiplex biomarker analysis can improve diagnostic accuracy and understanding of osteoporosis.
- Existing methods for simultaneous biomarker detection are often complex or less efficient.
Purpose of the Study:
- To develop and validate an Enzyme-Linked Immunosorbent Assay (ELISA) array for simultaneous detection of osteoporosis-relevant biomarkers.
- To assess the performance characteristics of the developed ELISA array.
- To compare the results obtained from the ELISA array with traditional ELISA methods.
Main Methods:
- Construction of a novel ELISA array platform.
- Evaluation of ELISA array performance using commercial antigens.
- Validation of the ELISA array using traditional ELISA for serum sample analysis.
Main Results:
- The developed ELISA array demonstrated good repeatability.
- Established linear ranges and limits of detection for four key osteoporosis biomarkers.
- High correlation observed between ELISA array measurements and traditional ELISA for serum samples.
Conclusions:
- The ELISA array-based immunoassay is a viable and efficient method for multiplexed measurement of osteoporosis biomarkers.
- This technology can advance the diagnostic and research capabilities in osteoporosis.
- Multiplex biomarker detection offers a promising avenue for improved osteoporosis management.
Keywords:
ELISA arrayN-terminal propeptide of type I collagenbone turnover markersosteocalcinosteoporosis biomarkersparathyroid hormone
